250 related articles for article (PubMed ID: 12379292)
1. Virus safety of human blood, plasma, and derived products.
Guertler L
Thromb Res; 2002 Oct; 107 Suppl 1():S39-45. PubMed ID: 12379292
[TBL] [Abstract][Full Text] [Related]
2. [Viruses and unconventional transmissible agents: update on transmission via blood ].
Barin F
Transfus Clin Biol; 2000 Jun; 7 Suppl 1():5s-10s. PubMed ID: 10919217
[TBL] [Abstract][Full Text] [Related]
3. Transfusion-transmissible infections.
Vrielink H; Reesink HW
Curr Opin Hematol; 1998 Nov; 5(6):396-405. PubMed ID: 9814646
[TBL] [Abstract][Full Text] [Related]
4. Beyond HIV, HBV and HCV--how to deal with other viruses?
Minor PD
Dev Biol (Basel); 2002; 108():15-9. PubMed ID: 12220138
[TBL] [Abstract][Full Text] [Related]
5. Transfusion-transmitted infectious diseases.
Allain JP; Stramer SL; Carneiro-Proietti AB; Martins ML; Lopes da Silva SN; Ribeiro M; Proietti FA; Reesink HW
Biologicals; 2009 Apr; 37(2):71-7. PubMed ID: 19231236
[TBL] [Abstract][Full Text] [Related]
6. Blood-borne viral infections.
Gürtler L
Blood Coagul Fibrinolysis; 1994 Dec; 5 Suppl 3():S5-10; discussion S11-2. PubMed ID: 7749048
[TBL] [Abstract][Full Text] [Related]
7. Virus inactivation of fresh plasma.
Mohr H
Vox Sang; 1998; 74 Suppl 2():171-2. PubMed ID: 9704442
[No Abstract] [Full Text] [Related]
8. [The blood-born viral infections].
Nakamura Y
Rinsho Byori; 1998 Feb; 46(2):107-18. PubMed ID: 9528333
[TBL] [Abstract][Full Text] [Related]
9. [Possibilities of virus inactivation of pooled fresh plasma with tri-n-butylphosphate (TNBP) detergents (SD procedure)].
Gürtler L
Infusionsther Transfusionsmed; 1994 Aug; 21 Suppl 1():77-9. PubMed ID: 8000260
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates.
Corash L
Vox Sang; 1998; 74 Suppl 2():173-6. PubMed ID: 9704443
[TBL] [Abstract][Full Text] [Related]
11. Safety procedures of coagulation factors.
Jorquera JI
Haemophilia; 2007 Dec; 13 Suppl 5(Suppl 5):41-6. PubMed ID: 18078396
[TBL] [Abstract][Full Text] [Related]
12. [Viral risks associated with blood transfusion].
Barin F
Rev Fr Transfus Hemobiol; 1993 Jan; 36(1):73-81. PubMed ID: 8386512
[TBL] [Abstract][Full Text] [Related]
13. Transfusion-transmitted disease.
Lee CA
Baillieres Clin Haematol; 1996 Jun; 9(2):369-94. PubMed ID: 8800511
[TBL] [Abstract][Full Text] [Related]
14. Estimating the pathogen safety of manufactured human plasma products: application to fibrin sealants and to thrombin.
Horowitz B; Busch M
Transfusion; 2008 Aug; 48(8):1739-53. PubMed ID: 18466171
[TBL] [Abstract][Full Text] [Related]
15. Transfusion virology: progress and challenges.
Simmonds P
Blood Rev; 1998 Sep; 12(3):171-7. PubMed ID: 9745887
[TBL] [Abstract][Full Text] [Related]
16. [Severe complications, adverse effects due to blood transfusion and its measures--transfusion transmitted viral infections].
Inaba S
Nihon Rinsho; 1997 Sep; 55(9):2320-6. PubMed ID: 9301297
[TBL] [Abstract][Full Text] [Related]
17. Analysis of human plasma products: polymerase chain reaction does not discriminate between live and inactivated viruses.
Hilfenhaus J; Gröner A; Nowak T; Weimer T
Transfusion; 1997 Sep; 37(9):935-40. PubMed ID: 9308641
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of viruses, bacteria, protozoa and leukocytes in platelet and red cell concentrates.
Corash L
Vox Sang; 2000; 78 Suppl 2():205-10. PubMed ID: 10938954
[TBL] [Abstract][Full Text] [Related]
19. Inactivation of infectious pathogens in labile blood components: meeting the challenge.
Corash L
Transfus Clin Biol; 2001 Jun; 8(3):138-45. PubMed ID: 11499954
[TBL] [Abstract][Full Text] [Related]
20. Approaches to minimize infection risk in blood banking and transfusion practice.
Lindholm PF; Annen K; Ramsey G
Infect Disord Drug Targets; 2011 Feb; 11(1):45-56. PubMed ID: 21303341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
